TWO SIGMA ADVISERS, LP - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2023$56,831
-82.5%
431,192
-32.4%
0.00%
-100.0%
Q2 2023$325,529
-66.0%
638,292
-58.0%
0.00%
-50.0%
Q1 2023$958,477
-23.8%
1,521,392
-21.5%
0.00%
-50.0%
Q4 2022$1,257,821
-44.1%
1,937,792
+48.0%
0.00%
-42.9%
Q3 2022$2,252,000
-6.9%
1,309,492
-32.9%
0.01%0.0%
Q2 2022$2,419,000
+35.5%
1,950,892
-28.7%
0.01%
+40.0%
Q1 2022$1,785,000
-50.1%
2,736,792
-16.6%
0.01%
-44.4%
Q4 2021$3,579,000
+85.2%
3,283,092
+209.3%
0.01%
+80.0%
Q3 2021$1,932,000
-24.5%
1,061,392
+9.4%
0.01%
-28.6%
Q2 2021$2,560,000
-26.2%
969,792
+0.7%
0.01%
-30.0%
Q1 2021$3,467,000
+54.8%
963,192
+8.4%
0.01%
+66.7%
Q4 2020$2,240,000
+78.6%
888,892
+78.6%
0.01%
+50.0%
Q3 2020$1,254,000
+243.6%
497,592
+347.5%
0.00%
+300.0%
Q2 2020$365,000
+78.0%
111,192
+32.7%
0.00%0.0%
Q1 2020$205,000
+978.9%
83,792
+737.9%
0.00%
Q4 2018$19,000
-80.4%
10,000
-47.9%
0.00%
-100.0%
Q4 2014$97,000
+185.3%
19,201
+48.8%
0.00%
Q3 2014$34,000
-63.8%
12,901
-44.6%
0.00%
-100.0%
Q2 2014$94,000
+59.3%
23,300
+82.0%
0.00%0.0%
Q1 2014$59,00012,8010.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
Third Security, LLC 9,709,607$60,394,0003.07%
MSD Partners, L.P. 3,410,500$21,213,0001.32%
MILLER VALUE PARTNERS, LLC 4,926,456$30,643,0001.24%
Michael & Susan Dell Foundation 66,749$415,0000.33%
ACUTA CAPITAL PARTNERS, LLC 150,000$933,0000.26%
Piermont Capital Management Inc. 85,500$532,0000.15%
A.R.T. Advisors, LLC 411,547$2,559,0000.14%
EQUITEC PROPRIETARY MARKETS, LLC 96,100$598,0000.14%
Vident Investment Advisory, LLC 204,744$1,274,0000.10%
EQUITEC PROPRIETARY MARKETS, LLC 68,800$428,0000.10%
View complete list of ZIOPHARM ONCOLOGY INC shareholders